PENTOSAN POLYSULFATE SODIUM

PENTOSAN POLYSULFATE SODIUM was reported 6931 times

PENTOSAN POLYSULFATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIGMENTARY MACULOPATHY 470 0.9751
1 HEREDITARY RETINAL DYSTROPHY 7 0.8750
2 RETINAL PIGMENTATION 607 0.7703
3 RETINAL DYSTROPHY 145 0.6092
4 DRY AGE-RELATED MACULAR DEGENERATION 562 0.5063
5 DELAYED DARK ADAPTATION 37 0.5000
6 MACULAR PIGMENTARY CHANGES 6 0.4286
7 CONE DYSTROPHY 3 0.4286
8 MACULOPATHY 1398 0.3937
9 MYOPIC CHORIORETINAL DEGENERATION 6 0.2727
10 RETINAL DRUSEN 42 0.2561
11 RETINAL PIGMENT EPITHELIUM CHANGE 7 0.2414
12 MACULAR PIGMENTATION 18 0.2143
13 THERMOPHOBIA 4 0.2105
14 MACULAR DYSTROPHY CONGENITAL 6 0.1935
15 CONE-ROD DYSTROPHY 3 0.1875
16 VITREOUS DEGENERATION 23 0.1402
17 CYSTITIS INTERSTITIAL 214 0.1329
18 AGE-RELATED MACULAR DEGENERATION 185 0.1218
19 GONADOTROPHIN DEFICIENCY 3 0.1111
20 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 141 0.1009
21 OPTIC DISC DRUSEN 6 0.0952
22 RETINAL INJURY 71 0.0920
23 PIGMENTARY GLAUCOMA 3 0.0811
24 ANTACID THERAPY 10 0.0769
25 EPIRETINAL MEMBRANE 20 0.0719
26 RETINAL DEGENERATION 92 0.0708
27 APPENDICOLITH 27 0.0698
28 RETINAL DEPIGMENTATION 21 0.0686
29 SLEEP DISORDER THERAPY 13 0.0657
30 BACTEROIDES INFECTION 16 0.0613
31 RETINAL PIGMENT EPITHELIOPATHY 26 0.0602
32 RETINAL TOXICITY 56 0.0544
33 CATARACT NUCLEAR 36 0.0540
34 COLON DYSPLASIA 14 0.0490
35 ACQUIRED PIGMENTED RETINOPATHY 3 0.0462
36 VITREOUS DETACHMENT 100 0.0461
37 ANALGESIC THERAPY 14 0.0436
38 VITREORETINAL TRACTION SYNDROME 4 0.0421
39 DRUG THERAPY 14 0.0413
40 ANTICOAGULANT THERAPY 10 0.0352
41 VITREOUS ADHESIONS 4 0.0348
42 RETINITIS PIGMENTOSA 8 0.0305
43 RETINOPATHY 107 0.0287
44 CENTRAL VISION LOSS 6 0.0269
45 EYE NAEVUS 3 0.0263
46 RECTAL OBSTRUCTION 3 0.0254
47 BLADDER PAIN 80 0.0252
48 MALIGNANT MELANOMA STAGE 0 5 0.0239
49 OESOPHAGOGASTRIC FUNDOPLASTY 4 0.0235
50 PROSTATIC PAIN 9 0.0221
51 CONGENITAL HIATUS HERNIA 5 0.0219
52 RETINOSCHISIS 3 0.0217
53 ADENOMATOUS POLYPOSIS COLI 3 0.0213
54 CHOROIDAL NEOVASCULARISATION 18 0.0210
55 MACULAR DEGENERATION 214 0.0179
56 EYELID EXFOLIATION 12 0.0152
57 CHORIORETINAL ATROPHY 3 0.0145
58 PRESBYOPIA 8 0.0144
59 ANAL ULCER 11 0.0135
60 RETINOPATHY HYPERTENSIVE 4 0.0132
61 CORNEAL DYSTROPHY 5 0.0120
62 TOTAL LUNG CAPACITY DECREASED 18 0.0113
63 CYSTOID MACULAR OEDEMA 21 0.0111
64 OBESITY SURGERY 3 0.0108
65 NIGHT BLINDNESS 15 0.0094
66 RETINAL SCAR 4 0.0087
67 BLADDER OPERATION 10 0.0086
68 URETHRAL PAIN 5 0.0085
69 HYPERPHOSPHATAEMIA 18 0.0084
70 MACULAR HOLE 11 0.0082
71 BLOOD PHOSPHORUS INCREASED 22 0.0080
72 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 7 0.0079
73 BLADDER IRRITATION 5 0.0078
74 LUNG OPACITY 18 0.0068
75 OPEN ANGLE GLAUCOMA 4 0.0065
76 BIOPSY BONE MARROW 3 0.0064
77 OPEN FRACTURE 3 0.0062
78 MACULAR FIBROSIS 4 0.0059
79 SUPRAPUBIC PAIN 3 0.0059
80 BLADDER SPASM 11 0.0059
81 OPHTHALMIC MIGRAINE 4 0.0058
82 AORTIC STENOSIS 20 0.0057
83 BLADDER DISCOMFORT 7 0.0056
84 COLOUR BLINDNESS 5 0.0054
85 GENERALISED ANXIETY DISORDER 8 0.0054
86 IRON DEFICIENCY 24 0.0053
87 KLEBSIELLA SEPSIS 6 0.0053
88 ASTIGMATISM 8 0.0053
89 RETINAL VASCULAR DISORDER 3 0.0051
90 MYOPIA 12 0.0050
91 EXCESSIVE CERUMEN PRODUCTION 3 0.0048
92 TUBERCULIN TEST POSITIVE 12 0.0047
93 RETINAL DISORDER 12 0.0046
94 CYSTOCELE 4 0.0046
95 BLADDER DILATATION 5 0.0046
96 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 4 0.0046
97 BLADDER DISORDER 44 0.0044
98 LIGAMENT DISORDER 4 0.0044
99 CENTRAL SEROUS CHORIORETINOPATHY 3 0.0044
100 FRACTURE NONUNION 6 0.0044
101 METAMORPHOPSIA 8 0.0043
102 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 4 0.0043
103 BORDERLINE PERSONALITY DISORDER 3 0.0042
104 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21 0.0041
105 RETINAL TEAR 10 0.0041
106 PYURIA 4 0.0040
107 CHROMATOPSIA 3 0.0040
108 PRODUCT DIFFICULT TO SWALLOW 4 0.0039
109 BLOOD URIC ACID INCREASED 22 0.0038
110 URINARY BLADDER HAEMORRHAGE 8 0.0038
111 JOINT CONTRACTURE 4 0.0037
112 POST-TRAUMATIC NECK SYNDROME 3 0.0037
113 CALCULUS BLADDER 5 0.0037
114 OCULAR TOXICITY 4 0.0036
115 MYASTHENIA GRAVIS 29 0.0036
116 ABNORMAL LOSS OF WEIGHT 24 0.0035
117 HYPOPHOSPHATAEMIA 26 0.0035
118 ALLODYNIA 4 0.0034
119 HYPERPLASIA 3 0.0033
120 APPENDICITIS 31 0.0033
121 EYE INJURY 10 0.0033
122 LARGE INTESTINE INFECTION 4 0.0033
123 INFUSION SITE BRUISING 7 0.0032
124 LARGE INTESTINE POLYP 22 0.0032
125 HYPERMETROPIA 3 0.0032
126 CYSTITIS NONINFECTIVE 4 0.0030
127 HYPOGONADISM 3 0.0030
128 INTERVERTEBRAL DISC COMPRESSION 3 0.0029
129 THERAPEUTIC RESPONSE DELAYED 8 0.0029
130 PRECANCEROUS CELLS PRESENT 4 0.0028
131 CHORIORETINOPATHY 4 0.0028
132 COMPLEX REGIONAL PAIN SYNDROME 4 0.0027
133 POST-TRAUMATIC STRESS DISORDER 18 0.0027
134 COELIAC DISEASE 26 0.0026
135 METABOLIC SURGERY 3 0.0026
136 LUMBAR RADICULOPATHY 3 0.0026
137 BACTERIAL VAGINOSIS 4 0.0026
138 VITREOUS FLOATERS 25 0.0025
139 ENDOMETRIOSIS 12 0.0025
140 DYSPLASIA 3 0.0025
141 TROPONIN INCREASED 19 0.0025
142 OPTIC ATROPHY 4 0.0025
143 VENTRICULAR FIBRILLATION 27 0.0024
144 PRE-EXISTING CONDITION IMPROVED 15 0.0024
145 CHOLECYSTITIS CHRONIC 16 0.0024
146 GLUCOSE URINE PRESENT 3 0.0024
147 BLOOD BILIRUBIN ABNORMAL 3 0.0023
148 DRUG PRESCRIBING ERROR 45 0.0023
149 HYPOPITUITARISM 4 0.0023
150 BLOOD CALCIUM INCREASED 20 0.0023
151 HYPOVITAMINOSIS 3 0.0023
152 ULCER 35 0.0022
153 BLINDNESS 87 0.0021
154 HYPERTONIC BLADDER 6 0.0021
155 OCULAR HYPERTENSION 4 0.0021
156 OESOPHAGEAL CANDIDIASIS 8 0.0020
157 HAEMORRHAGE URINARY TRACT 5 0.0020
158 GENITAL HERPES 3 0.0020
159 NEURITIS 3 0.0019
160 MICTURITION URGENCY 22 0.0019
161 HYPERLIPIDAEMIA 23 0.0019
162 CARDIOGENIC SHOCK 27 0.0019
163 CYSTITIS 59 0.0019
164 RETINAL DETACHMENT 17 0.0018
165 COSTOCHONDRITIS 3 0.0018
166 SPLENIC RUPTURE 3 0.0018
167 MUCOUS STOOLS 9 0.0018
168 MAJOR DEPRESSION 13 0.0018
169 ATYPICAL FEMUR FRACTURE 5 0.0018
170 BILIARY DYSKINESIA 3 0.0018
171 HEPATIC CYST 6 0.0018
172 DYSPAREUNIA 8 0.0017
173 CERVICAL SPINAL STENOSIS 3 0.0017
174 SERUM FERRITIN DECREASED 3 0.0017
175 MICTURITION DISORDER 6 0.0017
176 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
177 VAGINAL INFECTION 8 0.0017
178 SPINAL COLUMN STENOSIS 8 0.0017
179 RETINAL HAEMORRHAGE 12 0.0017
180 WEIGHT ABNORMAL 4 0.0017
181 OFF LABEL USE 1404 0.0016
182 COLECTOMY 9 0.0016
183 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
184 VULVOVAGINAL DRYNESS 5 0.0015
185 VISUAL FIELD DEFECT 11 0.0015
186 NEURALGIA 37 0.0015
187 JOINT CREPITATION 3 0.0015
188 TEMPOROMANDIBULAR JOINT SYNDROME 4 0.0015
189 BLOOD TEST ABNORMAL 21 0.0015
190 SKIN ABRASION 7 0.0015
191 MIGRAINE WITH AURA 4 0.0015
192 VITREOUS HAEMORRHAGE 4 0.0014
193 PRODUCT USE ISSUE 272 0.0014
194 BACTERIAL INFECTION 27 0.0014
195 PROCTITIS 4 0.0014
196 HYPERKINESIA 3 0.0014
197 RETINAL VEIN OCCLUSION 4 0.0014
198 THERAPEUTIC REACTION TIME DECREASED 4 0.0014
199 BLOOD URINE PRESENT 26 0.0014
200 COLONOSCOPY 3 0.0014
201 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
202 IRRITABLE BOWEL SYNDROME 29 0.0014
203 TENDERNESS 14 0.0013
204 CALCINOSIS 3 0.0013
205 CHRONIC SINUSITIS 5 0.0013
206 AUTOIMMUNE THYROIDITIS 5 0.0013
207 PELVIC PAIN 24 0.0013
208 READING DISORDER 3 0.0013
209 METHAEMOGLOBINAEMIA 3 0.0013
210 DYSURIA 47 0.0013
211 DRY EYE 63 0.0013
212 EXPOSURE TO TOXIC AGENT 4 0.0012
213 FIBROMYALGIA 30 0.0012
214 GOUT 22 0.0012
215 SENSITIVE SKIN 9 0.0012
216 VISUAL IMPAIRMENT 151 0.0012
217 CARTILAGE INJURY 3 0.0012
218 END STAGE RENAL DISEASE 22 0.0012
219 THYROID FUNCTION TEST ABNORMAL 5 0.0012
220 IRON DEFICIENCY ANAEMIA 11 0.0012
221 MEDICATION RESIDUE 3 0.0012
222 HERNIA REPAIR 3 0.0012
223 MULTIPLE ALLERGIES 9 0.0011
224 BLOOD POTASSIUM ABNORMAL 3 0.0011
225 ABDOMINAL MASS 3 0.0011
226 COMPRESSION FRACTURE 6 0.0011
227 DECUBITUS ULCER 9 0.0011
228 POLLAKIURIA 46 0.0011
229 CLUMSINESS 3 0.0011
230 THYROID NEOPLASM 3 0.0011
231 INCREASED TENDENCY TO BRUISE 10 0.0011
232 PLEURITIC PAIN 3 0.0011
233 POLYP 7 0.0011
234 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
235 ALOPECIA 206 0.0010
236 SKIN ATROPHY 6 0.0010
237 VULVOVAGINAL PAIN 5 0.0010
238 FOOD ALLERGY 8 0.0010
239 EYE DISORDER 34 0.0010
240 PRODUCT LABEL ISSUE 7 0.0010
241 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 73 0.0010
242 VITAMIN D DEFICIENCY 10 0.0010
243 CROHN'S DISEASE 7 0.0010
244 WRONG TECHNIQUE IN DRUG USAGE PROCESS 36 0.0010
245 ENURESIS 4 0.0010
246 IRITIS 3 0.0010
247 BLOOD CHOLESTEROL INCREASED 46 0.0010
248 SPINAL FUSION SURGERY 4 0.0010
249 PATHOLOGICAL FRACTURE 5 0.0010
250 DRY THROAT 10 0.0010
251 TENDONITIS 15 0.0010
252 ASCITES 28 0.0010
253 ABDOMINAL ADHESIONS 3 0.0009
254 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
255 BREAST CANCER RECURRENT 3 0.0009
256 PHOTOPSIA 6 0.0009
257 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
258 PRODUCT PHYSICAL ISSUE 19 0.0009
259 BRUXISM 5 0.0009
260 HYSTERECTOMY 8 0.0009
261 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
262 SURGERY 54 0.0009
263 ANXIETY DISORDER 3 0.0009
264 TREATMENT NONCOMPLIANCE 49 0.0009
265 MACULAR OEDEMA 5 0.0009
266 CATARACT 53 0.0009
267 ANAL INCONTINENCE 8 0.0009
268 VISION BLURRED 121 0.0009
269 GINGIVAL PAIN 7 0.0009
270 ADVERSE EVENT 81 0.0009
271 TOXICITY TO VARIOUS AGENTS 148 0.0009
272 COLITIS ULCERATIVE 39 0.0009
273 EYE OPERATION 4 0.0009
274 CHRONIC MYELOID LEUKAEMIA 4 0.0009
275 KIDNEY INFECTION 17 0.0009
276 HYPOPNOEA 3 0.0009
277 NEPHROGENIC ANAEMIA 4 0.0009
278 BLINDNESS UNILATERAL 12 0.0008
279 PHOTOPHOBIA 16 0.0008
280 URINE ODOUR ABNORMAL 5 0.0008
281 HAND FRACTURE 6 0.0008
282 GLOSSITIS 3 0.0008
283 FOOT FRACTURE 16 0.0008
284 BLOOD IRON DECREASED 10 0.0008
285 CATARACT OPERATION 5 0.0008
286 BODY HEIGHT DECREASED 9 0.0008
287 FACIAL BONES FRACTURE 3 0.0008
288 HORMONE LEVEL ABNORMAL 4 0.0008
289 VULVOVAGINAL BURNING SENSATION 5 0.0008
290 HYPOMANIA 3 0.0008
291 EYE INFECTION 9 0.0008
292 SNORING 3 0.0008
293 IMPAIRED DRIVING ABILITY 9 0.0008
294 COLITIS 30 0.0008
295 KLEBSIELLA INFECTION 4 0.0008
296 GALLBLADDER DISORDER 14 0.0008
297 DEPRESSION 178 0.0008
298 OESOPHAGEAL DISORDER 3 0.0008
299 DRY MOUTH 63 0.0008
300 POOR VENOUS ACCESS 8 0.0008
301 POOR QUALITY DRUG ADMINISTERED 5 0.0008
302 OPTIC NEURITIS 7 0.0008
303 GASTROINTESTINAL INFLAMMATION 6 0.0008
304 SUSPECTED COUNTERFEIT PRODUCT 3 0.0008
305 WALKING AID USER 5 0.0008
306 INCONTINENCE 8 0.0008
307 FOREIGN BODY 3 0.0007
308 BLEPHARITIS 3 0.0007
309 LIVER FUNCTION TEST INCREASED 16 0.0007
310 ORGAN FAILURE 3 0.0007
311 NOCTURIA 9 0.0007
312 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
313 GOITRE 3 0.0007
314 HYPERAESTHESIA 6 0.0007
315 DEAFNESS UNILATERAL 4 0.0007
316 ANKLE FRACTURE 11 0.0007
317 MIGRAINE 67 0.0007
318 URINARY TRACT INFECTION 119 0.0007
319 DRUG DOSE OMISSION 115 0.0007
320 HIATUS HERNIA 9 0.0007
321 INCORRECT DOSE ADMINISTERED 158 0.0007
322 CHAPPED LIPS 3 0.0007
323 URINARY RETENTION 23 0.0007
324 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
325 SLEEP APNOEA SYNDROME 13 0.0007
326 HYPERCHLORHYDRIA 4 0.0007
327 BACK DISORDER 11 0.0007
328 GLAUCOMA 13 0.0007
329 PLEURISY 4 0.0007
330 FEELING DRUNK 5 0.0007
331 HERNIA 13 0.0007
332 INCORRECT ROUTE OF DRUG ADMINISTRATION 24 0.0007
333 HEARING IMPAIRED 4 0.0007
334 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
335 SINUS DISORDER 13 0.0007
336 MENISCUS INJURY 4 0.0006
337 SYNOVIAL CYST 3 0.0006
338 PIGMENTATION DISORDER 4 0.0006
339 RENAL FUNCTION TEST ABNORMAL 3 0.0006
340 SCOLIOSIS 4 0.0006
341 BIPOLAR DISORDER 7 0.0006
342 GASTRIC DISORDER 22 0.0006
343 FLANK PAIN 6 0.0006
344 ASPIRATION 7 0.0006
345 MUSCULOSKELETAL DISCOMFORT 11 0.0006
346 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
347 SEASONAL ALLERGY 9 0.0006
348 DRUG SCREEN POSITIVE 5 0.0006
349 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 33 0.0006
350 EXPIRED PRODUCT ADMINISTERED 21 0.0006
351 DIABETES MELLITUS 48 0.0006
352 FAECAL INCONTINENCE 3 0.0006
353 CARDIAC FLUTTER 4 0.0006
354 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
355 INFLAMMATORY BOWEL DISEASE 6 0.0006
356 CHOLECYSTECTOMY 7 0.0006
357 ANXIETY 174 0.0006
358 HYPOGAMMAGLOBULINAEMIA 4 0.0006
359 JOINT INJURY 13 0.0006
360 ESCHERICHIA INFECTION 5 0.0006
361 SKIN HAEMORRHAGE 9 0.0006
362 TOOTH INFECTION 8 0.0006
363 DIABETIC NEUROPATHY 3 0.0006
364 RESTLESS LEGS SYNDROME 11 0.0006
365 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
366 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
367 SENSATION OF FOREIGN BODY 5 0.0006
368 PRODUCT COLOUR ISSUE 3 0.0006
369 PERIPHERAL VASCULAR DISORDER 3 0.0006
370 STOMACH DISCOMFORT 3 0.0006
371 JOINT EFFUSION 4 0.0006
372 BLOOD MAGNESIUM DECREASED 5 0.0006
373 PSYCHOLOGICAL TRAUMA 5 0.0006
374 PANIC ATTACK 21 0.0006
375 ABDOMINAL DISTENSION 60 0.0006
376 INTENTIONAL DRUG MISUSE 12 0.0006
377 DEFAECATION URGENCY 4 0.0006
378 RENAL PAIN 6 0.0006
379 PULMONARY TOXICITY 4 0.0006
380 PHARYNGOLARYNGEAL PAIN 3 0.0006
381 HAEMORRHOIDS 11 0.0006
382 HAEMATOCHEZIA 31 0.0006
383 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
384 FACIAL PAIN 5 0.0006
385 PRODUCT SIZE ISSUE 3 0.0006
386 POOR QUALITY SLEEP 12 0.0006
387 GINGIVITIS 3 0.0006
388 PHARYNGITIS STREPTOCOCCAL 6 0.0006
389 PANIC REACTION 4 0.0006
390 ERYTHEMA OF EYELID 3 0.0006
391 LUPUS-LIKE SYNDROME 5 0.0006
392 CHOLELITHIASIS 18 0.0005
393 JAW DISORDER 3 0.0005
394 SINUSITIS 56 0.0005
395 ROTATOR CUFF SYNDROME 7 0.0005
396 FOOT DEFORMITY 6 0.0005
397 SLEEP DISORDER 38 0.0005
398 PRODUCT DOSE OMISSION 35 0.0005
399 ORAL CANDIDIASIS 7 0.0005
400 SKIN TOXICITY 3 0.0005
401 BONE PAIN 31 0.0005
402 DERMATITIS CONTACT 6 0.0005
403 EAR INFECTION 14 0.0005
404 SWELLING 49 0.0005
405 THROMBOSIS 42 0.0005
406 THYROID DISORDER 8 0.0005
407 AUTOIMMUNE DISORDER 5 0.0005
408 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 92 0.0005
409 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
410 LYMPHOCYTE COUNT DECREASED 9 0.0005
411 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
412 ODYNOPHAGIA 3 0.0005
413 HYPOTHYROIDISM 16 0.0005
414 SENSORY LOSS 4 0.0005
415 RHINITIS 4 0.0005
416 PAIN 304 0.0005
417 ABDOMINAL PAIN 115 0.0005
418 MUSCLE DISORDER 4 0.0005
419 MUSCULOSKELETAL STIFFNESS 43 0.0005
420 RECTAL HAEMORRHAGE 21 0.0005
421 HYPERSOMNIA 14 0.0005
422 SPINAL OPERATION 6 0.0005
423 HEART RATE IRREGULAR 11 0.0005
424 OSTEOPOROSIS 20 0.0005
425 THINKING ABNORMAL 9 0.0005
426 MENSTRUAL DISORDER 4 0.0005
427 DRUG EFFECT DECREASED 26 0.0005
428 HYPOKINESIA 7 0.0005
429 TOOTH EXTRACTION 6 0.0005
430 THROAT TIGHTNESS 13 0.0005
431 FUNGAL INFECTION 16 0.0005
432 NASAL DRYNESS 3 0.0005
433 SOMNOLENCE 96 0.0005
434 INFUSION SITE SWELLING 3 0.0005
435 DRUG INTOLERANCE 46 0.0005
436 DISCOMFORT 29 0.0005
437 KNEE ARTHROPLASTY 10 0.0005
438 ABDOMINAL PAIN LOWER 12 0.0005
439 DRUG ADMINISTERED AT INAPPROPRIATE SITE 5 0.0005
440 CANDIDA INFECTION 8 0.0005
441 INADEQUATE ANALGESIA 4 0.0005
442 MOOD SWINGS 15 0.0005
443 VITAMIN D DECREASED 4 0.0005
444 DYSPEPSIA 46 0.0005
445 EAR PAIN 9 0.0005
446 APPLICATION SITE VESICLES 3 0.0005
447 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
448 HYPONATRAEMIA 26 0.0005
449 PULMONARY THROMBOSIS 5 0.0005
450 URINE OUTPUT DECREASED 4 0.0005
451 NAIL DISORDER 4 0.0005
452 BEDRIDDEN 6 0.0005
453 BURNING SENSATION 32 0.0005
454 GROIN PAIN 4 0.0005
455 DYSGRAPHIA 3 0.0005
456 SPINAL OSTEOARTHRITIS 4 0.0005
457 DISABILITY 9 0.0005
458 GASTROINTESTINAL PAIN 5 0.0005
459 TOOTH FRACTURE 5 0.0005
460 LUNG INFILTRATION 4 0.0005
461 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
462 EYE HAEMORRHAGE 6 0.0004
463 BREAST MASS 3 0.0004
464 CONSTIPATION 97 0.0004
465 POSTOPERATIVE WOUND INFECTION 3 0.0004
466 ABDOMINAL DISCOMFORT 74 0.0004
467 IMPAIRED GASTRIC EMPTYING 6 0.0004
468 UNDERDOSE 32 0.0004
469 EXOSTOSIS 4 0.0004
470 NIGHT SWEATS 14 0.0004
471 NERVE COMPRESSION 4 0.0004
472 BLOOD POTASSIUM DECREASED 13 0.0004
473 HYPERTRANSAMINASAEMIA 3 0.0004
474 PERSONALITY CHANGE 4 0.0004
475 EXTRASYSTOLES 3 0.0004
476 MASS 6 0.0004
477 DIARRHOEA HAEMORRHAGIC 4 0.0004
478 EYE PAIN 24 0.0004
479 HOT FLUSH 32 0.0004
480 INTENTIONAL PRODUCT MISUSE 37 0.0004
481 RESPIRATORY TRACT INFECTION 11 0.0004
482 IMPAIRED WORK ABILITY 9 0.0004
483 EYE INFLAMMATION 4 0.0004
484 PRURITUS GENERALISED 9 0.0004
485 FAECES DISCOLOURED 9 0.0004
486 HYPERCHOLESTEROLAEMIA 4 0.0004
487 NEPHROLITHIASIS 19 0.0004
488 ABDOMINAL PAIN UPPER 85 0.0004
489 HEPATIC ENZYME INCREASED 28 0.0004
490 THERAPY CESSATION 21 0.0004
491 DISTURBANCE IN ATTENTION 22 0.0004
492 ROAD TRAFFIC ACCIDENT 17 0.0004
493 URINARY INCONTINENCE 12 0.0004
494 ARTHROPOD BITE 3 0.0004
495 LIGAMENT SPRAIN 4 0.0004
496 MOOD ALTERED 11 0.0004
497 OEDEMA PERIPHERAL 49 0.0004
498 UPPER LIMB FRACTURE 8 0.0004
499 HYDRONEPHROSIS 3 0.0004
500 HYPOTONIA 4 0.0004
501 OVARIAN CYST 4 0.0004
502 PULMONARY EMBOLISM 38 0.0004
503 SECRETION DISCHARGE 5 0.0004
504 BREAST TENDERNESS 3 0.0004
505 HYPOAESTHESIA ORAL 6 0.0004
506 COLD SWEAT 7 0.0004
507 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
508 FEELING COLD 11 0.0004
509 CHRONIC KIDNEY DISEASE 30 0.0004
510 PLEURAL EFFUSION 24 0.0004
511 SUICIDAL IDEATION 36 0.0004
512 DISSOCIATION 3 0.0004
513 PROCEDURAL COMPLICATION 3 0.0004
514 GASTROINTESTINAL DISORDER 35 0.0004
515 MENTAL DISORDER 17 0.0004
516 PHARYNGEAL OEDEMA 6 0.0004
517 EAR DISCOMFORT 4 0.0004
518 INFUSION SITE PAIN 5 0.0004
519 MUSCULOSKELETAL CHEST PAIN 6 0.0004
520 TEMPERATURE INTOLERANCE 4 0.0004
521 APHTHOUS ULCER 3 0.0004
522 PELVIC FRACTURE 3 0.0004
523 BASAL CELL CARCINOMA 6 0.0004
524 BONE DISORDER 7 0.0004
525 DEAFNESS 10 0.0004
526 HYPERTENSION 81 0.0004
527 GASTRITIS 10 0.0004
528 HAEMATURIA 13 0.0004
529 JOINT DISLOCATION 4 0.0004
530 PNEUMOTHORAX 6 0.0004
531 LIVER FUNCTION TEST ABNORMAL 11 0.0004
532 CONDITION AGGRAVATED 115 0.0004
533 BLOOD ALBUMIN DECREASED 3 0.0004
534 HEADACHE 237 0.0004
535 RENAL CYST 3 0.0004
536 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
537 NECK PAIN 21 0.0004
538 BREAST PAIN 4 0.0004
539 STENT PLACEMENT 3 0.0004
540 HYPOACUSIS 16 0.0004
541 FLATULENCE 21 0.0004
542 SINUS CONGESTION 5 0.0004
543 TINNITUS 17 0.0004
544 POST PROCEDURAL INFECTION 3 0.0004
545 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
546 BLOOD CREATININE INCREASED 24 0.0004
547 GINGIVAL BLEEDING 5 0.0004
548 ABNORMAL FAECES 3 0.0004
549 OESOPHAGITIS 4 0.0004
550 WEIGHT DECREASED 102 0.0004
551 HYPERHIDROSIS 47 0.0004
552 BRONCHITIS 27 0.0004
553 PERIPHERAL COLDNESS 5 0.0004
554 PRODUCT ADHESION ISSUE 13 0.0004
555 GENERAL PHYSICAL HEALTH DETERIORATION 42 0.0004
556 DENTAL CARIES 4 0.0004
557 PROCEDURAL PAIN 10 0.0004
558 NERVE INJURY 4 0.0004
559 MUSCLE SPASMS 66 0.0004
560 INJECTION SITE RASH 11 0.0004
561 COORDINATION ABNORMAL 5 0.0004
562 APHONIA 5 0.0004
563 DRUG EFFECT INCOMPLETE 13 0.0004
564 ORAL PAIN 8 0.0004
565 PRODUCTIVE COUGH 17 0.0004
566 FEMUR FRACTURE 11 0.0004
567 ASTHMA 40 0.0004
568 MITRAL VALVE INCOMPETENCE 4 0.0004
569 METRORRHAGIA 6 0.0004
570 NAUSEA 278 0.0004
571 INTERNAL HAEMORRHAGE 4 0.0003
572 INSOMNIA 93 0.0003
573 MUSCLE STRAIN 3 0.0003
574 ADVERSE DRUG REACTION 31 0.0003
575 FEEDING DISORDER 7 0.0003
576 PSORIATIC ARTHROPATHY 14 0.0003
577 BACK PAIN 80 0.0003
578 POST PROCEDURAL HAEMORRHAGE 4 0.0003
579 SPINAL PAIN 4 0.0003
580 SEPSIS 38 0.0003
581 RIB FRACTURE 7 0.0003
582 DYSPHAGIA 32 0.0003
583 COLON CANCER 5 0.0003
584 MALAISE 147 0.0003
585 ACCIDENT 4 0.0003
586 HAEMOLYTIC ANAEMIA 3 0.0003
587 WRIST FRACTURE 4 0.0003
588 THYROID CANCER 4 0.0003
589 GASTROENTERITIS VIRAL 6 0.0003
590 MOUTH ULCERATION 7 0.0003
591 LACRIMATION INCREASED 10 0.0003
592 ARTHRITIS 26 0.0003
593 LIP DRY 3 0.0003
594 BURSITIS 4 0.0003
595 OSTEOPENIA 5 0.0003
596 PRESYNCOPE 8 0.0003
597 RESTLESSNESS 12 0.0003
598 PALPITATIONS 38 0.0003
599 OROPHARYNGEAL PAIN 30 0.0003
600 TENDON RUPTURE 4 0.0003
601 LIMB DISCOMFORT 10 0.0003
602 HEART RATE INCREASED 32 0.0003
603 DIARRHOEA 208 0.0003
604 HEPATIC STEATOSIS 6 0.0003
605 SWOLLEN TONGUE 10 0.0003
606 LEUKAEMIA 3 0.0003
607 PRODUCT USE COMPLAINT 5 0.0003
608 FEELING ABNORMAL 76 0.0003
609 SPINAL DISORDER 3 0.0003
610 MUSCLE ATROPHY 4 0.0003
611 PRODUCT PACKAGING ISSUE 3 0.0003
612 JOINT SWELLING 38 0.0003
613 TOOTH DISORDER 7 0.0003
614 DIZZINESS 157 0.0003
615 OBESITY 5 0.0003
616 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
617 LYMPHADENOPATHY 11 0.0003
618 ERUCTATION 6 0.0003
619 FALL 103 0.0003
620 ANAEMIA 59 0.0003
621 DIPLOPIA 8 0.0003
622 CHOKING 6 0.0003
623 AMNESIA 20 0.0003
624 OSTEOARTHRITIS 13 0.0003
625 MENORRHAGIA 6 0.0003
626 HEPATOMEGALY 3 0.0003
627 PARAESTHESIA 48 0.0003
628 THERAPY CHANGE 3 0.0003
629 IMPAIRED HEALING 10 0.0003
630 IMMUNE SYSTEM DISORDER 4 0.0003
631 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
632 BLOOD UREA INCREASED 5 0.0003
633 MALIGNANT MELANOMA 4 0.0003
634 APHASIA 9 0.0003
635 VOMITING 140 0.0003
636 TYPE 2 DIABETES MELLITUS 10 0.0003
637 PRODUCT ADMINISTRATION ERROR 6 0.0003
638 FREQUENT BOWEL MOVEMENTS 8 0.0003
639 EYELID PTOSIS 3 0.0003
640 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
641 WEIGHT INCREASED 66 0.0003
642 LIMB INJURY 8 0.0003
643 SLUGGISHNESS 3 0.0003
644 PALLOR 8 0.0003
645 HYPOAESTHESIA 44 0.0003
646 DRUG TOXICITY 4 0.0003
647 EUPHORIC MOOD 3 0.0003
648 CORONARY ARTERY OCCLUSION 4 0.0003
649 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
650 INFLAMMATION 15 0.0003
651 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
652 THROAT IRRITATION 13 0.0003
653 MENTAL IMPAIRMENT 7 0.0003
654 ARTHRALGIA 120 0.0003
655 ORAL DISCOMFORT 4 0.0003
656 PETECHIAE 3 0.0003
657 WITHDRAWAL SYNDROME 12 0.0003
658 SYRINGE ISSUE 5 0.0003
659 CARPAL TUNNEL SYNDROME 4 0.0003
660 PAIN IN EXTREMITY 84 0.0003
661 HEART RATE DECREASED 10 0.0003
662 CONFUSIONAL STATE 46 0.0003
663 ASTHENIA 107 0.0003
664 HEAD DISCOMFORT 5 0.0003
665 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
666 EATING DISORDER 6 0.0003
667 THERAPEUTIC RESPONSE DECREASED 17 0.0003
668 RED BLOOD CELL COUNT DECREASED 8 0.0003
669 FEELING HOT 17 0.0003
670 PARAESTHESIA ORAL 4 0.0003
671 VAGINAL HAEMORRHAGE 12 0.0003
672 INJECTION SITE REACTION 19 0.0003
673 OSTEOMYELITIS 5 0.0003
674 BACK INJURY 3 0.0003
675 INJECTION SITE HAEMATOMA 4 0.0003
676 CHEST PAIN 51 0.0003
677 FLUID RETENTION 14 0.0003
678 CRYING 10 0.0003
679 BLOOD PRESSURE INCREASED 42 0.0003
680 DYSPHONIA 16 0.0003
681 CHEST DISCOMFORT 28 0.0003
682 VISUAL ACUITY REDUCED 9 0.0003
683 SKIN DISORDER 9 0.0003
684 DRUG INEFFECTIVE 354 0.0003
685 PULMONARY MASS 4 0.0003
686 MALNUTRITION 3 0.0003
687 NERVOUSNESS 14 0.0003
688 SKIN INFECTION 3 0.0003
689 OCULAR DISCOMFORT 3 0.0003
690 FISTULA 3 0.0003
691 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
692 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 54 0.0003
693 GAIT DISTURBANCE 51 0.0003
694 FLUSHING 27 0.0003
695 BLOOD SODIUM DECREASED 5 0.0003
696 UNEVALUABLE EVENT 20 0.0003
697 PRODUCT AVAILABILITY ISSUE 6 0.0003
698 MUSCULOSKELETAL DISORDER 5 0.0003
699 HERPES ZOSTER 15 0.0003
700 DRUG ADMINISTRATION ERROR 8 0.0003
701 CONTUSION 25 0.0003
702 METASTASES TO LUNG 3 0.0003
703 MADAROSIS 3 0.0003
704 PRESCRIBED OVERDOSE 5 0.0003
705 DECREASED APPETITE 60 0.0003
706 HAEMORRHAGE 27 0.0003
707 ELECTROLYTE IMBALANCE 3 0.0003
708 CELLULITIS 13 0.0003
709 CAESAREAN SECTION 3 0.0003
710 BREAST CANCER 24 0.0003
711 ORAL HERPES 5 0.0003
712 RENAL FAILURE 34 0.0003
713 FATIGUE 199 0.0003
714 MUSCULAR WEAKNESS 29 0.0003
715 DEHYDRATION 34 0.0003
716 BALANCE DISORDER 22 0.0003
717 MYALGIA 43 0.0003
718 HAEMATOCRIT DECREASED 5 0.0003
719 CHOLECYSTITIS 3 0.0003
720 RESPIRATORY TRACT CONGESTION 4 0.0003
721 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
722 PRODUCT QUALITY ISSUE 34 0.0003
723 SPINAL FRACTURE 5 0.0002
724 IRRITABILITY 15 0.0002
725 SPEECH DISORDER 13 0.0002
726 MEMORY IMPAIRMENT 34 0.0002
727 SWELLING FACE 16 0.0002
728 BODY TEMPERATURE INCREASED 5 0.0002
729 CARDIOMEGALY 3 0.0002
730 INJECTION SITE EXTRAVASATION 3 0.0002
731 HYPERCALCAEMIA 3 0.0002
732 PHOTOSENSITIVITY REACTION 4 0.0002
733 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
734 CYST 3 0.0002
735 APPLICATION SITE IRRITATION 3 0.0002
736 EPISTAXIS 18 0.0002
737 POISONING 3 0.0002
738 DERMATITIS 5 0.0002
739 INTRAOCULAR PRESSURE INCREASED 3 0.0002
740 MYDRIASIS 3 0.0002
741 PARANOIA 4 0.0002
742 OCULAR HYPERAEMIA 11 0.0002
743 BLISTER 13 0.0002
744 INJECTION SITE INDURATION 3 0.0002
745 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
746 MULTIPLE SCLEROSIS 11 0.0002
747 VERTIGO 14 0.0002
748 LOCAL SWELLING 4 0.0002
749 INCORRECT PRODUCT STORAGE 3 0.0002
750 MELAENA 5 0.0002
751 APPLICATION SITE PAIN 5 0.0002
752 HYPERSENSITIVITY 42 0.0002
753 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
754 LIVER DISORDER 10 0.0002
755 TACHYCARDIA 20 0.0002
756 TRANSAMINASES INCREASED 5 0.0002
757 PRODUCT DOSE OMISSION ISSUE 66 0.0002
758 HAEMOGLOBIN DECREASED 23 0.0002
759 THIRST 4 0.0002
760 JOINT RANGE OF MOTION DECREASED 3 0.0002
761 GLOSSODYNIA 5 0.0002
762 ILLNESS 23 0.0002
763 JAUNDICE 6 0.0002
764 CHROMATURIA 5 0.0002
765 OEDEMA 12 0.0002
766 TOOTHACHE 4 0.0002
767 APPLICATION SITE PRURITUS 5 0.0002
768 WHEEZING 13 0.0002
769 INFLUENZA LIKE ILLNESS 18 0.0002
770 PRURITUS 84 0.0002
771 MOVEMENT DISORDER 7 0.0002
772 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
773 ABNORMAL DREAMS 6 0.0002
774 TREMOR 36 0.0002
775 ARTHROPATHY 12 0.0002
776 MEDICATION ERROR 12 0.0002
777 CONJUNCTIVITIS 4 0.0002
778 HUNGER 3 0.0002
779 HAEMOPTYSIS 6 0.0002
780 EYE SWELLING 8 0.0002
781 MIDDLE INSOMNIA 4 0.0002
782 PYREXIA 73 0.0002
783 COVID-19 37 0.0002
784 GASTRIC ULCER 4 0.0002
785 VIRAL INFECTION 7 0.0002
786 PRODUCT PRESCRIBING ERROR 5 0.0002
787 INCREASED APPETITE 4 0.0002
788 RASH ERYTHEMATOUS 10 0.0002
789 EXPOSURE DURING PREGNANCY 13 0.0002
790 URTICARIA 35 0.0002
791 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
792 EYE PRURITUS 7 0.0002
793 POST PROCEDURAL COMPLICATION 4 0.0002
794 ANOSMIA 3 0.0002
795 HYPERTHYROIDISM 3 0.0002
796 DYSSTASIA 6 0.0002
797 DYSPNOEA 116 0.0002
798 LOSS OF CONSCIOUSNESS 26 0.0002
799 ABASIA 5 0.0002
800 OSTEONECROSIS OF JAW 5 0.0002
801 RENAL INJURY 6 0.0002
802 DYSGEUSIA 15 0.0002
803 DISORIENTATION 8 0.0002
804 INJECTION SITE BRUISING 16 0.0002
805 DEEP VEIN THROMBOSIS 13 0.0002
806 PREGNANCY 4 0.0002
807 CORONARY ARTERY DISEASE 6 0.0002
808 STOMATITIS 12 0.0002
809 PRODUCT COMPLAINT 5 0.0002
810 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
811 DEVICE FAILURE 3 0.0002
812 PLATELET COUNT DECREASED 21 0.0002
813 INSURANCE ISSUE 3 0.0002
814 BLOOD PRESSURE DECREASED 13 0.0002
815 HYPOPHAGIA 5 0.0002
816 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
817 MOBILITY DECREASED 14 0.0002
818 RASH 84 0.0002
819 CONVULSION 11 0.0002
820 PNEUMONIA 62 0.0002
821 PSORIASIS 25 0.0002
822 BRAIN FOG 3 0.0002
823 MUSCULOSKELETAL PAIN 10 0.0002
824 APPLICATION SITE ERYTHEMA 5 0.0002
825 JOINT STIFFNESS 5 0.0002
826 HALLUCINATION, VISUAL 4 0.0002
827 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
828 DRUG INTERACTION 30 0.0002
829 COUGH 53 0.0002
830 DYSARTHRIA 7 0.0002
831 FEAR 5 0.0002
832 MUSCLE TIGHTNESS 3 0.0002
833 BLOOD BILIRUBIN INCREASED 5 0.0002
834 RASH PRURITIC 10 0.0002
835 MULTIPLE FRACTURES 3 0.0002
836 STAPHYLOCOCCAL INFECTION 6 0.0002
837 INFUSION RELATED REACTION 12 0.0002
838 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
839 DIVERTICULITIS 5 0.0002
840 LIP SWELLING 6 0.0002
841 GAIT INABILITY 6 0.0002
842 CHILLS 21 0.0002
843 NEUROPATHY PERIPHERAL 17 0.0002
844 PERICARDITIS 3 0.0002
845 RASH PAPULAR 4 0.0002
846 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
847 HEMIPARESIS 3 0.0002
848 AGITATION 13 0.0002
849 PAIN IN JAW 5 0.0002
850 INJECTION SITE HAEMORRHAGE 14 0.0002
851 SCAR 3 0.0002
852 ANGINA PECTORIS 5 0.0002
853 SKIN DISCOLOURATION 8 0.0002
854 MUSCLE TWITCHING 4 0.0002
855 RASH MACULAR 6 0.0002
856 INJURY 12 0.0002
857 METASTASES TO LIVER 3 0.0002
858 PANCREATITIS 9 0.0002
859 DEPRESSED MOOD 9 0.0002
860 NASAL CONGESTION 10 0.0002
861 LABORATORY TEST ABNORMAL 5 0.0002
862 INJECTION SITE ERYTHEMA 21 0.0002
863 INFECTION 24 0.0002
864 HYPERGLYCAEMIA 6 0.0002
865 INJECTION SITE PRURITUS 11 0.0002
866 LUNG DISORDER 8 0.0002
867 INJECTION SITE URTICARIA 4 0.0002
868 LIVER INJURY 4 0.0002
869 NASOPHARYNGITIS 30 0.0002
870 INFLUENZA 18 0.0002
871 NERVOUS SYSTEM DISORDER 5 0.0002
872 PNEUMONIA ASPIRATION 4 0.0002
873 INJECTION SITE PAIN 49 0.0002
874 HALLUCINATION 12 0.0002
875 HYPOCALCAEMIA 3 0.0002
876 FRACTURE 3 0.0002
877 HEAD INJURY 5 0.0002
878 PROTEINURIA 3 0.0002
879 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
880 EYE IRRITATION 9 0.0002
881 SEROTONIN SYNDROME 3 0.0002
882 LOWER LIMB FRACTURE 3 0.0002
883 PERIPHERAL SWELLING 24 0.0002
884 HIP FRACTURE 5 0.0002
885 RASH GENERALISED 4 0.0002
886 BLOOD PRESSURE ABNORMAL 3 0.0002
887 ERYTHEMA 31 0.0002
888 FEBRILE NEUTROPENIA 10 0.0002
889 ACUTE KIDNEY INJURY 23 0.0002
890 MENSTRUATION IRREGULAR 4 0.0001
891 EMOTIONAL DISTRESS 18 0.0001
892 ANGER 5 0.0001
893 ARRHYTHMIA 7 0.0001
894 INJECTION SITE WARMTH 3 0.0001
895 RESPIRATORY ARREST 4 0.0001
896 ANAPHYLACTIC REACTION 8 0.0001
897 NIGHTMARE 5 0.0001
898 RETCHING 3 0.0001
899 SKIN BURNING SENSATION 10 0.0001
900 LETHARGY 8 0.0001
901 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
902 CEREBROVASCULAR ACCIDENT 23 0.0001
903 INJECTION SITE MASS 5 0.0001
904 STEVENS-JOHNSON SYNDROME 3 0.0001
905 PULMONARY OEDEMA 6 0.0001
906 SNEEZING 3 0.0001
907 ATRIAL FIBRILLATION 13 0.0001
908 DYSPNOEA EXERTIONAL 5 0.0001
909 INTESTINAL OBSTRUCTION 5 0.0001
910 RHEUMATOID ARTHRITIS 15 0.0001
911 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
912 ACNE 10 0.0001
913 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
914 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
915 PERICARDIAL EFFUSION 3 0.0001
916 PLASMA CELL MYELOMA 5 0.0001
917 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
918 ABNORMAL BEHAVIOUR 5 0.0001
919 NEUTROPENIA 17 0.0001
920 BLOOD GLUCOSE DECREASED 6 0.0001
921 LOCALISED INFECTION 3 0.0001
922 INTERSTITIAL LUNG DISEASE 6 0.0001
923 HOSPITALISATION 19 0.0001
924 EXTRA DOSE ADMINISTERED 5 0.0001
925 RESPIRATORY FAILURE 9 0.0001
926 DYSKINESIA 5 0.0001
927 NEUTROPHIL COUNT DECREASED 5 0.0001
928 LUNG NEOPLASM MALIGNANT 5 0.0001
929 SEIZURE 14 0.0001
930 AGEUSIA 3 0.0001
931 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
932 HAEMATOMA 3 0.0001
933 DELIRIUM 4 0.0001
934 SEDATION 3 0.0001
935 ANHEDONIA 3 0.0001
936 DRUG WITHDRAWAL SYNDROME 10 0.0001
937 DEVICE MALFUNCTION 8 0.0001
938 SYNCOPE 11 0.0001
939 RESPIRATORY DISTRESS 3 0.0001
940 RHINORRHOEA 7 0.0001
941 MENTAL STATUS CHANGES 3 0.0001
942 DEMENTIA 3 0.0001
943 HEPATIC FUNCTION ABNORMAL 4 0.0001
944 COGNITIVE DISORDER 5 0.0001
945 TARDIVE DYSKINESIA 3 0.0001
946 INTENTIONAL DOSE OMISSION 3 0.0001
947 DRY SKIN 14 0.0001
948 HYPOTENSION 21 0.0001
949 PRODUCT SUBSTITUTION ISSUE 6 0.0001
950 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
951 PSYCHOTIC DISORDER 3 0.0001
952 LEUKOPENIA 5 0.0001
953 AGGRESSION 5 0.0001
954 ABORTION SPONTANEOUS 4 0.0001
955 EMOTIONAL DISORDER 3 0.0001
956 OVERDOSE 20 0.0001
957 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
958 OXYGEN SATURATION DECREASED 5 0.0001
959 CARDIAC FAILURE CONGESTIVE 7 0.0001
960 HYPOKALAEMIA 4 0.0001
961 RENAL DISORDER 4 0.0001
962 HYPERKALAEMIA 3 0.0001
963 CARDIAC DISORDER 8 0.0001
964 HYPOGLYCAEMIA 4 0.0001
965 ILL-DEFINED DISORDER 5 0.0001
966 DRUG DEPENDENCE 13 0.0001
967 INJECTION SITE SWELLING 6 0.0001
968 DEVICE BREAKAGE 3 0.0001
969 CARDIO-RESPIRATORY ARREST 3 0.0001
970 PANCYTOPENIA 4 0.0001
971 RENAL IMPAIRMENT 6 0.0001
972 SKIN EXFOLIATION 6 0.0001
973 RENAL FAILURE ACUTE 3 0.0001
974 THERAPY INTERRUPTED 5 0.0001
975 BLOOD GLUCOSE INCREASED 13 0.0001
976 MYOCARDIAL INFARCTION 12 0.0001
977 DEVICE ISSUE 6 0.0001
978 NO ADVERSE EVENT 12 0.0001
979 SKIN IRRITATION 3 0.0001
980 DEATH 54 0.0001
981 TREATMENT FAILURE 5 0.0001
982 COMPLETED SUICIDE 5 0.0001
983 DISEASE PROGRESSION 7 0.0001
984 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
985 BLADDER CANCER 3 0.0001
986 CARDIAC FAILURE 4 0.0000
987 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
988 CARDIAC ARREST 4 0.0000
989 NEOPLASM MALIGNANT 3 0.0000
990 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
991 THROMBOCYTOPENIA 5 0.0000
992 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000